Pharmaceuticals in China - Market Summary, Competitive Analysis and Forecast, 2016-2025
Pharmaceuticals in China - Market @Summary, Competitive Analysis and Forecast, 2016-2025
SUMMARY
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Chinese pharmaceuticals market had total revenues of $169.4bn in 2020, representing a compound annual growth rate (CAGR) of 11.9% between 2016 and 2020.
- Government initiatives such as Made in China 2025 are helping to drive market growth through significant investment in new technologies and the expansion of domestic manufacturing capacity in biopharmaceuticals.
- A changing regulatory landscape has caused the Chinese market to become increasingly attractive and accessible to foreign players, which has helped to boost market growth.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in China
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts
- What was the size of the China pharmaceuticals market by value in 2020?
- What will be the size of the China pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the China pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up China's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do players in the Chinese pharmaceuticals market face?
8 COMPANY PROFILES
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceutical Co Ltd
8.3. Yunnan Baiyao Group Co Ltd
8.4. Guangzhou Pharmaceutical Holdings Ltd
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths of leading players?
7.4. What strategies do leading players follow?
7.5. What threats do players in the Chinese pharmaceuticals market face?
8 COMPANY PROFILES
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceutical Co Ltd
8.3. Yunnan Baiyao Group Co Ltd
8.4. Guangzhou Pharmaceutical Holdings Ltd
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: China pharmaceuticals market value: $ billion, 2016-20
Table 2: China pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: China pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: China pharmaceuticals market share: % share, by value, 2020
Table 5: Yangtze River Pharmaceutical Group: key facts
Table 6: Yangtze River Pharmaceutical Group: Key Employees
Table 7: Shanghai Pharmaceutical Co Ltd: key facts
Table 8: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 10: Yunnan Baiyao Group Co Ltd: key facts
Table 11: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios
Table 12: Yunnan Baiyao Group Co Ltd: Key Employees
Table 13: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 14: Guangzhou Pharmaceutical Holdings Ltd: Key Employees
Table 15: China size of population (million), 2016-20
Table 16: China gdp (constant 2005 prices, $ billion), 2016-20
Table 17: China gdp (current prices, $ billion), 2016-20
Table 18: China inflation, 2016-20
Table 19: China consumer price index (absolute), 2016-20
Table 20: China exchange rate, 2016-20
Table 1: China pharmaceuticals market value: $ billion, 2016-20
Table 2: China pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: China pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: China pharmaceuticals market share: % share, by value, 2020
Table 5: Yangtze River Pharmaceutical Group: key facts
Table 6: Yangtze River Pharmaceutical Group: Key Employees
Table 7: Shanghai Pharmaceutical Co Ltd: key facts
Table 8: Shanghai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 9: Shanghai Pharmaceutical Co Ltd: Key Employees
Table 10: Yunnan Baiyao Group Co Ltd: key facts
Table 11: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios
Table 12: Yunnan Baiyao Group Co Ltd: Key Employees
Table 13: Guangzhou Pharmaceutical Holdings Ltd: key facts
Table 14: Guangzhou Pharmaceutical Holdings Ltd: Key Employees
Table 15: China size of population (million), 2016-20
Table 16: China gdp (constant 2005 prices, $ billion), 2016-20
Table 17: China gdp (current prices, $ billion), 2016-20
Table 18: China inflation, 2016-20
Table 19: China consumer price index (absolute), 2016-20
Table 20: China exchange rate, 2016-20
LIST OF FIGURES
Figure 1: China pharmaceuticals market value: $ billion, 2016-20
Figure 2: China pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: China pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in China, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in China, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in China, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in China, 2020
Figure 10: China pharmaceuticals market share: % share, by value, 2020
Figure 1: China pharmaceuticals market value: $ billion, 2016-20
Figure 2: China pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: China pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in China, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in China, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in China, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in China, 2020
Figure 10: China pharmaceuticals market share: % share, by value, 2020
